Ophthalmology Glaucoma, a journal collaboration between the American Academy of Ophthalmology and the American Glaucoma Society, provides a stimulating forum for discussion of clinical and scientific issues of greatest concern to clinicians who care for glaucoma patients. Each issue presents original articles on new approaches to diagnosis, innovations in pharmacological therapy and surgical technique, and basic science advances that impact clinical practice. Ophthalmology Glaucoma is the official journal of the American Glaucoma Society.
Disclaimer Notice: Statements and opinions expressed in Ophthalmology Glaucoma are those of the author(s) and are not necessarily those of the Academy or publisher, or indicative of Academy views, policy or editorial concurrence. The Editor(s), the Academy, and the Publisher assume no responsibility for any injury and/or damage to persons or property as a matter of product liability, negligence, or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein including those in a language other than English. No suggested test or procedure should be carried out unless, in the reader's judgment, its risk is justified and the patient has received information sufficient to give a fully informed consent. Because of the rapid advances in the medical sciences, medical practitioners should obtain independent verification of diagnoses and drug dosages. Discussions, views, and recommendations as to medical procedures, choice of drugs, and drug dosages are the responsibility of the authors. Consumers should consult with their own doctors about their individual health status before making any health decisions. The Academy does not endorse companies, drugs or other products.